<DOC>
	<DOCNO>NCT03017625</DOCNO>
	<brief_summary>Chronic obstructive pulmonary disease ( COPD ) know development severe cardiovascular co-morbidities . Systemic inflammation acute exacerbation COPD ( AE-COPD ) think play role development cardiovascular disease . Platelets contribute acute cardiovascular event atherosclerosis . When platelet activate , form complex monocyte . These platelet-monocyte complex ( PMCs ) early process atherothrombosis promote inflammation . In COPD , platelet function AE-COPD scarcely study . This study aim address gap investigate platelet function coagulation patient AE-COPD convalescence .</brief_summary>
	<brief_title>Platelet Activation Reactivity Acute Exacerbations COPD</brief_title>
	<detailed_description />
	<criteria>&gt; 40 year Spirometry confirm diagnosis COPD ( i.e . postbronchodilator FEV1/FVC &lt; 70 % le 12 % reversibility test &lt; Lower limit normal ( LLN ) ) â‰¥10 pack year smoke Use anticoagulation platelet function inhibitor Asthma Chronic inflammatory disease , example rheumatoid arthritis , psoriasis , inflammatory bowel disease , systemic lupus erythematous ( SLE ) Malignancies</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>COPD</keyword>
	<keyword>Cardiovascular Disease</keyword>
	<keyword>Platelets</keyword>
	<keyword>Inflammation</keyword>
</DOC>